Cargando…

SUN-392 Bone Mineral Density and Body Mass Index in Men with Cystic Fibrosis

Osteoporosis is an important endocrine complication of cystic fibrosis (CF). Low bone mass in CF patients has multiple contributing causes including vitamin D deficiency, calcium malabsorption, pulmonary infection and cytokine production, malnutrition, a sedentary life style, cumulative steroid dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Jawahar, Abhinaya, Krishnasamy, Sathya S, Ramirez, Allan, O’Hagan, Adrian, Winters, Stephen J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207563/
http://dx.doi.org/10.1210/jendso/bvaa046.1256
_version_ 1783530634435624960
author Jawahar, Abhinaya
Krishnasamy, Sathya S
Ramirez, Allan
O’Hagan, Adrian
Winters, Stephen J
author_facet Jawahar, Abhinaya
Krishnasamy, Sathya S
Ramirez, Allan
O’Hagan, Adrian
Winters, Stephen J
author_sort Jawahar, Abhinaya
collection PubMed
description Osteoporosis is an important endocrine complication of cystic fibrosis (CF). Low bone mass in CF patients has multiple contributing causes including vitamin D deficiency, calcium malabsorption, pulmonary infection and cytokine production, malnutrition, a sedentary life style, cumulative steroid dose, delayed puberty, and hypogonadism. The objective of this study was to examine the relationship between BMI and bone density of the hip and spine in adult men with CF. We conducted a retrospective chart review of adult men with CF receiving care at an academic medical center. Medical records of 43 men ages 19-60 (32.1±9.8) years were reviewed. 8 men with lung transplant, or receiving chronic glucocorticoid or androgen treatment were excluded. One subject was excluded as his BMI was >3SD above the mean. BMD was measured by dual-energy x-ray absorptiometry at the lumbar spine (LS) and hip. The mean ± SD BMI of the study population was 24.10 ± 5.24 kg/m(2)(,) mean LS BMD was 0.96 ± 0.204 g/cm(2) and mean hip BMD was 0.701 ± 0.382 g/cm(2). Men were divided into three groups: normal BMD, osteopenia, or osteoporosis, based on current guidelines. 8 (24%) men were found to have normal bone density (Z=0.40±0.60), 19 (56%) had osteopenia (Z= -1.57±0.67) and 7 (20%) had osteoporosis (Z= -3.27±0.83). Of these 7, 6 had osteoporosis of the LS only, and one patient had osteoporosis of the hip; 5 were being treated with a bisphosphonate. The three groups of men were similar in age (P=0.93). 25OH-vitamin D levels were 22.6±4.4, 35.6±12.7 and 27.0±13.4 ng/mL, respectively (p=0.03). There was a significant (p=0.023) difference in BMI among these three groups (26.33±4.80 vs 23.25 ± 3.01 vs 20.96±3.64 kg/m(2)). BMI was strongly positively correlated with LS BMD (r = 0.54, P<0.001) but not with BMD of the hip (r = 0.11, p=0.55). Moreover, LS BMD was highly predicted by body weight (r = 0.90, P<0.0001) but not significantly by height (r = 0.26, p=0.16). These findings indicate that CF-related bone disease (CF-RBD) affecting the LS is common in adult men, and that body weight is a major determinant of LS BMD in men with CF. Possible mechanisms for this association include signaling pathways related to nutritional status and sex steroids.
format Online
Article
Text
id pubmed-7207563
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72075632020-05-13 SUN-392 Bone Mineral Density and Body Mass Index in Men with Cystic Fibrosis Jawahar, Abhinaya Krishnasamy, Sathya S Ramirez, Allan O’Hagan, Adrian Winters, Stephen J J Endocr Soc Bone and Mineral Metabolism Osteoporosis is an important endocrine complication of cystic fibrosis (CF). Low bone mass in CF patients has multiple contributing causes including vitamin D deficiency, calcium malabsorption, pulmonary infection and cytokine production, malnutrition, a sedentary life style, cumulative steroid dose, delayed puberty, and hypogonadism. The objective of this study was to examine the relationship between BMI and bone density of the hip and spine in adult men with CF. We conducted a retrospective chart review of adult men with CF receiving care at an academic medical center. Medical records of 43 men ages 19-60 (32.1±9.8) years were reviewed. 8 men with lung transplant, or receiving chronic glucocorticoid or androgen treatment were excluded. One subject was excluded as his BMI was >3SD above the mean. BMD was measured by dual-energy x-ray absorptiometry at the lumbar spine (LS) and hip. The mean ± SD BMI of the study population was 24.10 ± 5.24 kg/m(2)(,) mean LS BMD was 0.96 ± 0.204 g/cm(2) and mean hip BMD was 0.701 ± 0.382 g/cm(2). Men were divided into three groups: normal BMD, osteopenia, or osteoporosis, based on current guidelines. 8 (24%) men were found to have normal bone density (Z=0.40±0.60), 19 (56%) had osteopenia (Z= -1.57±0.67) and 7 (20%) had osteoporosis (Z= -3.27±0.83). Of these 7, 6 had osteoporosis of the LS only, and one patient had osteoporosis of the hip; 5 were being treated with a bisphosphonate. The three groups of men were similar in age (P=0.93). 25OH-vitamin D levels were 22.6±4.4, 35.6±12.7 and 27.0±13.4 ng/mL, respectively (p=0.03). There was a significant (p=0.023) difference in BMI among these three groups (26.33±4.80 vs 23.25 ± 3.01 vs 20.96±3.64 kg/m(2)). BMI was strongly positively correlated with LS BMD (r = 0.54, P<0.001) but not with BMD of the hip (r = 0.11, p=0.55). Moreover, LS BMD was highly predicted by body weight (r = 0.90, P<0.0001) but not significantly by height (r = 0.26, p=0.16). These findings indicate that CF-related bone disease (CF-RBD) affecting the LS is common in adult men, and that body weight is a major determinant of LS BMD in men with CF. Possible mechanisms for this association include signaling pathways related to nutritional status and sex steroids. Oxford University Press 2020-05-08 /pmc/articles/PMC7207563/ http://dx.doi.org/10.1210/jendso/bvaa046.1256 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Bone and Mineral Metabolism
Jawahar, Abhinaya
Krishnasamy, Sathya S
Ramirez, Allan
O’Hagan, Adrian
Winters, Stephen J
SUN-392 Bone Mineral Density and Body Mass Index in Men with Cystic Fibrosis
title SUN-392 Bone Mineral Density and Body Mass Index in Men with Cystic Fibrosis
title_full SUN-392 Bone Mineral Density and Body Mass Index in Men with Cystic Fibrosis
title_fullStr SUN-392 Bone Mineral Density and Body Mass Index in Men with Cystic Fibrosis
title_full_unstemmed SUN-392 Bone Mineral Density and Body Mass Index in Men with Cystic Fibrosis
title_short SUN-392 Bone Mineral Density and Body Mass Index in Men with Cystic Fibrosis
title_sort sun-392 bone mineral density and body mass index in men with cystic fibrosis
topic Bone and Mineral Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207563/
http://dx.doi.org/10.1210/jendso/bvaa046.1256
work_keys_str_mv AT jawaharabhinaya sun392bonemineraldensityandbodymassindexinmenwithcysticfibrosis
AT krishnasamysathyas sun392bonemineraldensityandbodymassindexinmenwithcysticfibrosis
AT ramirezallan sun392bonemineraldensityandbodymassindexinmenwithcysticfibrosis
AT ohaganadrian sun392bonemineraldensityandbodymassindexinmenwithcysticfibrosis
AT wintersstephenj sun392bonemineraldensityandbodymassindexinmenwithcysticfibrosis